In the BioHarmony Drug Report Database
Buprenorphine
Butrans, Sublocade, Buvidal, Sixmo (buprenorphine) is a small molecule pharmaceutical. Buprenorphine was first approved as Butrans on 2010-06-30. It is used to treat heroin dependence and pain in the USA. It has been approved in Europe to treat opioid-related disorders. The pharmaceutical is active against mu-type opioid receptor and kappa-type opioid receptor. Buprenorphine hcl’s patents are valid until 2038-06-22 (FDA).
Trade Name
|
Buvidal, Sixmo |
|---|---|
Common Name
|
buprenorphine |
ChEMBL ID
|
CHEMBL511142 |
Indication
|
heroin dependence, opioid-related disorders, pain |
Drug Class
|
Image (chem structure or protein)